# FDA Inspection 1034059 - Daniel Rutrick, MD - September 12, 2017

Source: https://www.keypedia.com/records/fda_inspections/daniel-rutrick-md/76e450c1-d8da-495c-8a08-710fcf81df8b
Source feed: FDA_Inspections

> FDA Inspection 1034059 for Daniel Rutrick, MD on September 12, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1034059
- Company Name: Daniel Rutrick, MD
- Inspection Date: 2017-09-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1249630 - 2024-09-11](https://www.keypedia.com/records/fda_inspections/daniel-rutrick-md/38747e2c-1257-4a4a-9339-b541571a5c4a)
- [FDA Inspection 1249630 - 2024-09-11](https://www.keypedia.com/records/fda_inspections/daniel-rutrick-md/4c01119a-99cf-488c-8ac5-ee3844288ab8)

Company: https://www.keypedia.com/companies/daniel-rutrick-md/a7675597-78b0-45de-9bfe-68d92a60d903

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c